These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38798437)

  • 1. Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular Risk.
    Zhu J; Jhang J; Yu H; Mushlin AI; Kamel H; Alemayehu N; Giardina JC; Gupta A; Pandya A
    medRxiv; 2024 May; ():. PubMed ID: 38798437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
    Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
    JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effect and Cost-Effectiveness of Screening for Asymptomatic Carotid Stenosis: A Markov Model.
    Högberg D; Mani K; Wanhainen A; Svensjö S
    Eur J Vasc Endovasc Surg; 2018 Jun; 55(6):819-827. PubMed ID: 29636252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients.
    Pandya A; Gupta A; Kamel H; Navi BB; Sanelli PC; Schackman BR
    Radiology; 2015 Feb; 274(2):455-63. PubMed ID: 25225841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of screening for asymptomatic carotid stenosis.
    Yin D; Carpenter JP
    J Vasc Surg; 1998 Feb; 27(2):245-55. PubMed ID: 9510279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis.
    Gupta A; Mushlin AI; Kamel H; Navi BB; Pandya A
    Radiology; 2015 Dec; 277(3):763-72. PubMed ID: 26098459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease.
    Pouwels XGLV; van Mil D; Kieneker LM; Boersma C; van Etten RW; Evers-Roeten B; Heerspink HJL; Hemmelder MH; Langelaan MLP; Thelen MHM; Gansevoort RT; Koffijberg H
    EClinicalMedicine; 2024 Feb; 68():102414. PubMed ID: 38299045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of carotid endarterectomy in asymptomatic patients.
    Cronenwett JL; Birkmeyer JD; Nackman GB; Fillinger MF; Bech FR; Zwolak RM; Walsh DB
    J Vasc Surg; 1997 Feb; 25(2):298-309; discussion 310-1. PubMed ID: 9052564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis.
    Baradaran H; Gupta A; Anzai Y; Mushlin AI; Kamel H; Pandya A
    J Am Heart Assoc; 2019 Nov; 8(21):e012739. PubMed ID: 31645165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.
    Kazi DS; Moran AE; Coxson PG; Penko J; Ollendorf DA; Pearson SD; Tice JA; Guzman D; Bibbins-Domingo K
    JAMA; 2016 Aug; 316(7):743-53. PubMed ID: 27533159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals.
    Spahillari A; Zhu J; Ferket BS; Hunink MGM; Carr JJ; Terry JG; Nelson C; Mwasongwe S; Mentz RJ; O'Brien EC; Correa A; Shah RV; Murthy VL; Pandya A
    JAMA Cardiol; 2020 Aug; 5(8):871-880. PubMed ID: 32401264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.
    Fonarow GC; Keech AC; Pedersen TR; Giugliano RP; Sever PS; Lindgren P; van Hout B; Villa G; Qian Y; Somaratne R; Sabatine MS
    JAMA Cardiol; 2017 Oct; 2(10):1069-1078. PubMed ID: 28832867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early detection of asymptomatic carotid disease in patients with obliterative arteriosclerosis of the lower extremities].
    Rancić Z; Radak D; Stojanović D
    Srp Arh Celok Lek; 2002; 130(7-8):258-64. PubMed ID: 12585003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated Cost-effectiveness of Medical Therapy, Sleeve Gastrectomy, and Gastric Bypass in Patients With Severe Obesity and Type 2 Diabetes.
    Lauren BN; Lim F; Krikhely A; Taveras EM; Woo Baidal JA; Bellows BK; Hur C
    JAMA Netw Open; 2022 Feb; 5(2):e2148317. PubMed ID: 35157054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons.
    Lee TT; Solomon NA; Heidenreich PA; Oehlert J; Garber AM
    Ann Intern Med; 1997 Mar; 126(5):337-46. PubMed ID: 9054277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness Analysis of Anatomic vs Functional Index Testing in Patients With Low-Risk Stable Chest Pain.
    Karády J; Mayrhofer T; Ivanov A; Foldyna B; Lu MT; Ferencik M; Pursnani A; Salerno M; Udelson JE; Mark DB; Douglas PS; Hoffmann U
    JAMA Netw Open; 2020 Dec; 3(12):e2028312. PubMed ID: 33315111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Axicabtagene Ciloleucel and Tisagenlecleucel as Second-line or Later Therapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
    Choe JH; Abdel-Azim H; Padula WV; Abou-El-Enein M
    JAMA Netw Open; 2022 Dec; 5(12):e2245956. PubMed ID: 36520440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
    Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
    Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.